A detailed history of Ubs Asset Management Americas Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 205,756 shares of ARCT stock, worth $3.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
205,756
Previous 205,552 0.1%
Holding current value
$3.4 Million
Previous $5.01 Million 4.6%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.08 - $25.38 $3,688 - $5,177
204 Added 0.1%
205,756 $4.78 Million
Q2 2024

Aug 13, 2024

BUY
$24.35 - $44.39 $612,499 - $1.12 Million
25,154 Added 13.94%
205,552 $5.01 Million
Q1 2024

May 15, 2024

BUY
$31.23 - $42.99 $4.82 Million - $6.64 Million
154,444 Added 595.07%
180,398 $6.09 Million
Q4 2023

Feb 14, 2024

BUY
$17.71 - $32.97 $47,940 - $89,249
2,707 Added 11.64%
25,954 $818,000
Q3 2023

Nov 13, 2023

BUY
$25.44 - $37.35 $161,594 - $237,247
6,352 Added 37.6%
23,247 $593,000
Q1 2023

May 15, 2023

BUY
$14.72 - $23.97 $248,694 - $404,973
16,895 New
16,895 $404,000
Q2 2022

Aug 12, 2022

SELL
$12.26 - $31.17 $216,903 - $551,459
-17,692 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$34.2 - $47.56 $42,852 - $59,592
-1,253 Reduced 6.61%
17,692 $654,000
Q3 2021

Nov 15, 2021

BUY
$27.88 - $58.25 $7,499 - $15,669
269 Added 1.44%
18,945 $905,000
Q2 2021

Aug 16, 2021

BUY
$25.79 - $42.11 $63,211 - $103,211
2,451 Added 15.11%
18,676 $631,000
Q1 2021

May 14, 2021

BUY
$38.75 - $86.92 $62,968 - $141,245
1,625 Added 11.13%
16,225 $670,000
Q4 2020

Mar 01, 2021

BUY
$34.61 - $123.66 $10,383 - $37,098
300 Added 2.1%
14,600 $633,000
Q3 2020

Nov 13, 2020

BUY
$37.49 - $63.19 $119,968 - $202,208
3,200 Added 28.83%
14,300 $613,000
Q2 2020

Aug 14, 2020

BUY
$12.66 - $58.27 $140,526 - $646,797
11,100 New
11,100 $518,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.